| For: | Liu P, Chen J. Targeting SHP2: Dual breakthroughs in colorectal cancer therapy–from signaling pathway modulation to immune microenvironment remodeling. World J Gastrointest Oncol 2025; 17(7): 107380 [PMID: 40697246 DOI: 10.4251/wjgo.v17.i7.107380] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v17/i7/107380.htm |
| Number | Citing Articles |
| 1 |
Iris Dirven, Celina Ang, Cleo Bertels, Koen Kortbeek, Amy de Haar‐Holleman, Marieke Vollebergh, Poulikos Poulikakos, Bart Neyns. The past, present, and future treatment of BRAFV600‐mutant metastatic colorectal cancer: A comprehensive review. Cancer 2026; 132(16) doi: 10.1002/cncr.70569
|
| 2 |
Wei Yen Chan, Ines Pires da Silva, Georgina V Long, Helen Rizos. Targeting MEK in cancer and beyond: mechanistic insights and therapeutic opportunities. The Lancet 2026; 407(10539) doi: 10.1016/S0140-6736(26)00199-6
|
| 3 |
Miguel Galán, Elena Hernández-García, Pablo Munné, Ana Redondo-Urzainqui, Francisco J. Cueto, Jon Sicilia, Sergio Callejas Alejano, M. Ascensión Rey-Martín, Ana Dopazo, David Sancho, Salvador Iborra. Loss of SHP-1 in CD11c+ cells impairs anti-tumor immunity. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1710547
|
| 4 |
Chenxiang Ding, Ruoyu Yao, Yong Wang, Hongjie Liu, Chunyan Li, Hua Xie. An overview of mechanisms, biomarkers, and treatment strategies for acquired anti-EGFR resistance in RAS wild-type colorectal cancer. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1656372
|
| 5 |
Sushan Wang, Xiaoqing Zhao, Jianhua Dong, Jing Zhang, Yuxin Wang, Honglian Jin, Xinyu Jiang, Li Chen, Ming Zhang, Lei Ji, Yawei Zhao. SHP2 as a pivotal modulator of the tumor microenvironment in gastrointestinal cancers: from mechanisms to targeted therapies. Journal of Translational Medicine 2026; 24(1) doi: 10.1186/s12967-026-08477-4
|
| 6 |
Sahar Iftikhar, Alexander H. Xiao, Zhaohui Jin, Emad H. Aly. KRAS in Colorectal Cancer: Tumorigenesis, Surgical Implications and Evolving Treatment Target. Current Oncology 2026; 33(9) doi: 10.3390/curroncol33090514
|
| 7 |
Mei Chan, Meghna Shelke, Amanda Townsend, Amitesh Roy, Vy Broadbridge, Christos Karapetis, Timothy Price. From undruggable to actionable: advances in KRAS targeting in colorectal cancer. Academia Oncology 2026; 3(1) doi: 10.20935/AcadOnco8216
|
| 8 |
Christian Bailly. Anticancer Activity of Demethylincisterol A3 and Related Incisterol-Type Fungal Products. Life 2025; 15(10) doi: 10.3390/life15101638
|